Healthcare Services

Large Volume Parenteral (LVP) Market Insights Highlighting Opportunities and Drivers Supporting Growth to 2030

April 2, 2026April 15, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Large Volume Parenteral (LVP) Market Evolve From 2026 To 2030?

The large volume parenteral (lvp) market size has shown strong growth over recent years. It is anticipated to increase from $13.53 billion in 2025 to $14.76 billion in 2026, reflecting a compound annual growth rate (CAGR) of 9.1%. The expansion observed historically is attributable to factors such as rising hospitalization rates, an increase in intravenous fluid therapy usage, more frequent surgical procedures, the development of critical care infrastructure, and the growth in infectious disease treatment.

The large volume parenteral (lvp) market is anticipated to experience robust expansion over the coming years. Projections indicate it will reach $21.37 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.7%. This anticipated growth during the forecast period is primarily driven by factors such as an aging global population, the escalating occurrence of chronic illnesses, a heightened need for parenteral nutrition, the development of healthcare infrastructure in developing economies, and an increase in emergency and trauma care provisions. Key trends anticipated during this period encompass a rising preference for non-PVC and environmentally friendly LVP packaging, the proliferation of pre-prepared and pre-mixed infusion solutions, an intensified emphasis on ensuring sterility and preventing contamination, the expanding application of LVPs in critical care and emergency medical settings, and an increase in the volume of hospital-based infusion therapies.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12195&type=smp

What Drivers Are Influencing The Large Volume Parenteral (LVP) Market?

The increasing incidence of long-term health conditions is projected to boost the expansion of the large-volume parenteral market in the future. These conditions are defined as illnesses or health issues that typically persist for at least three months and may deteriorate over time. The escalation in chronic disease cases is primarily attributed to factors such as tobacco consumption, exposure to smoke, and inadequate nutrition. Patients suffering from these conditions necessitate a suitable balance of vital nutrients to sustain their strength. Parenteral administration ensures precise drug dosages, as most medications are absorbed directly into the bloodstream, bypassing the digestive system. For example, data from September 2023, provided by the World Health Organization, a specialized United Nations agency based in Switzerland, indicated that 41 million deaths annually worldwide, representing 74% of all fatalities, were due to non-communicable diseases (NCDs) or chronic conditions. Consequently, the rising prevalence of chronic diseases is a key factor propelling the expansion of the large-volume parenteral market.

Which Segment Areas Are Covered In The Large Volume Parenteral (LVP) Market Analysis?

The large volume parenteral (lvp) market covered in this report is segmented –

1) By Type: Soft Bag LVP, Plastic Bag LVP, Glass Bottle LVP

2) By Volume: 100 ML – 250 ML, 250 ML – 500 ML, 500 ML – 1000 ML, 1000 ML -2000 ML, 2000 And More

3) By Application: Basic Infusion, Therapeutics Infusion, Nutritious Infusion

4) By End-User: Hospital, Medical Centers, Other End Users

Subsegments:

1) By Soft Bag LVP: PVC Soft Bags, Non-PVC Soft Bags

2) By Plastic Bag LVP: Polypropylene Bags, Polyethylene Bags

3) By Glass Bottle LVP: Single-Use Glass Bottles, Multi-Dose Glass Bottles

Which Trends Are Shaping The Future Of The Large Volume Parenteral (LVP) Market?

Leading companies in the large volume parenteral (LVP) market are focusing on developing smart infusion device innovations, such as intelligent large-volume infusion pumps. This approach aims to meet the growing demand for safer, more automated, and connected intravenous therapy, driven by the expansion of hospital-based infusion services, remote patient monitoring, and the need for standardized, error-resistant medication delivery. An intelligent large-volume infusion pump is designed to deliver high-volume IV fluids (LVP) and includes dose-error reduction software, connectivity to smart drug libraries, and advanced alarm management features. Unlike conventional infusion pumps that depend on manual programming and offer limited automation, these advanced systems help reduce dosing errors, ease workflow burdens, and integrate seamlessly with hospital IT infrastructure. For example, in April 2024, Baxter International Inc., a US-based pharmaceutical and medical device company, received U.S. FDA clearance for its Novum IQ Large-Volume Infusion Pump with Dose IQ smart-dose software. This device enables high-rate fluid delivery, including large-volume infusions, incorporates safety features such as drug library integration to minimize dosing errors, and supports connectivity with hospital electronic medical records and smart monitoring systems. By enabling safe, automated, and reliable administration of large fluid volumes, the Novum IQ pump helps healthcare providers improve infusion accuracy, reduce the risk of dosing errors, and streamline high-volume IV therapy processes.

Which Global Companies Are Actively Competing In The Large Volume Parenteral (LVP) Market?

Major companies operating in the large volume parenteral (lvp) market are Pfizer Inc., Fresenius Kabi AG, Abbott Laboratories Inc., Otsuka Holdings Co. Ltd., Baxter International Inc., B. Braun Melsungen AG, Grifols S.A., Cipla Limited, ICU Medical Inc., Biocon Limited, Sichuan Kelun Pharmaceutical Co. Ltd., Alembic Pharmaceuticals Limited, Cadila Healthcare Ltd., Gland Pharma Limited, Akums Drugs & Pharmaceuticals Ltd., Beximco Pharmaceutical Ltd., Taj Pharmaceuticals Limited, Albert David Ltd., Amanta Healthcare Ltd., Unique Pharmaceutical Laboratories Ltd., Ahlcon Parenterals India Ltd., Parenteral Drugs Limited, Abaris Healthcare Pvt. Ltd., BML Parenteral Drugs, Denis Chem Lab Ltd., Pentagon Labs Ltd., DJ Labs Pvt. Ltd., Higgs Healthcare

Read the full large volume parenteral (lvp) market report here:

https://www.thebusinessresearchcompany.com/report/large-volume-parenteral-lvp-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The Large Volume Parenteral (LVP) Market?

North America was the largest region in the large volume parenteral (LVP) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the large volume parenteral (lvp) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Large Volume Parenteral (LVP) Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12195&type=smp

Browse Through More Reports Similar to the Global Large Volume Parenteral (LVP) Market 2026, By The Business Research Company

Small Volume Parenteral Global Market Report

https://www.thebusinessresearchcompany.com/report/small-volume-parenteral-global-market-report

Small Volume Parenteral Global Market Report

https://www.thebusinessresearchcompany.com/report/small-volume-parenteral-global-market-report

Parenteral Nutrition Global Market Report

https://www.thebusinessresearchcompany.com/report/parenteral-nutrition-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795